Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Dec. 4, 2024
Cold
piezoelectric
plasma
(CPP)
is
a
novel
approach
in
cancer
therapy,
enabling
the
development
of
portable
treatment
devices
capable
triggering
cell
death.
While
its
effectiveness
remains
underexplored,
this
research
focuses
on
application
against
cholangiocarcinoma
(CCA),
an
aggressive
biliary
tract.
A
CPP
device
utilized
to
generate
either
corona
discharge
(Pz-CD)
or
dielectric
barrier
(Pz-DBD)
for
vitro
experiments.
Notably,
Pz-CD
can
deliver
more
power
than
Pz-DBD,
although
both
sources
produce
significant
levels
reactive
species
and
liquid
phases.
This
work
shows
that
causes
gradient
increase
medium
temperature
from
center
towards
edges
culture
well,
especially
longer
times.
Although
heats
significantly,
it
cools
quickly
after
extinction.
When
applied
human
CCA
cells,
immediate
long-term
effects,
localized
Pz-CD,
while
uniform
Pz-DBD.
Immediate
effects
result
also
actin
cytoskeleton
remodeling
without
alteration
membrane
permeability.
Long-term
CPP,
antioxidant
system
engaged,
include
activation
DNA
damage
response
pathway
leading
In
conclusion,
should
be
recognized
as
promising
antitumor
therapy.
Cancer Cell International,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: Dec. 1, 2023
Abstract
High
recurrence
and
metastasis
rates
poor
prognoses
are
the
major
challenges
of
current
cancer
therapy.
Mounting
evidence
suggests
that
stem
cells
(CSCs)
play
an
important
role
in
development,
chemoradiotherapy
resistance,
recurrence,
metastasis.
Therefore,
targeted
CSC
therapy
has
become
a
new
strategy
for
solving
problems
recurrence.
Since
properties
CSCs
regulated
by
specific
tumour
microenvironment,
so-called
niche,
which
targets
crosstalk
between
their
niches,
is
vital
our
pursuit
therapeutic
opportunities
to
prevent
from
recurring.
In
this
review,
we
aim
highlight
factors
within
niche
have
roles
regulating
properties,
including
extracellular
matrix
(ECM),
stromal
(e.g.,
associated
macrophages
(TAMs),
cancer-associated
fibroblasts
(CAFs),
mesenchymal
(MSCs)),
physiological
changes
inflammation,
hypoxia,
angiogenesis).
We
also
discuss
recent
progress
regarding
therapies
targeting
elucidate
developments
more
effective
strategies
eliminate
cancer.
Oral Diseases,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 24, 2024
Abstract
Objective
Cold
atmospheric
plasma
(CAP)
is
a
novel
approach
for
cancer
treatment.
It
can
be
used
to
treat
liquids—plasma‐activated
media
(PAM)—which
are
then
transferred
the
target
as
an
exogenous
source
of
reactive
oxygen
and
nitrogen
species
(RONS).
The
present
study
aimed
at
chemically
characterizing
different
PAM
assessing
their
in
vitro
selectivity
against
head
neck
cells
(HNC).
Methods
were
obtained
by
exposing
2
5
mL
cell
culture
medium
CAP
5,
10
20
min
6
mm
working
distance.
Anions
kinetics
was
evaluated
ion
chromatography.
Cell
proliferation
inhibition,
apoptosis
occurrence,
cycle
modifications
assessed
MTS
flow
cytometry,
on
human
epidermal
keratinocyte
(HaCaT)
HNC
lines
HSC3,
HSC4
A253.
Results
conditions
showed
significant
reduction
whereas
effect
milder,
but
time‐dependence
more
evident.
HaCaT
unaffected
PAM,
indicating
cells.
Conclusions
chemical
composition
modified
exposure
influenced
modulating
inducing
cells,
without
affecting
normal
Pharmacological Research,
Journal Year:
2025,
Volume and Issue:
unknown, P. 107720 - 107720
Published: March 1, 2025
Both
obesity
and
metabolic
disorders
are
global
medical
problems.
Driven
by
prolonged
inflammation,
increases
the
risk
of
developing
syndromes
such
as
fatty
liver,
diabetes,
cardiovascular
diseases
cancers.
The
fat
mass
obesity-associated
protein
(FTO)
is
an
m6A
demethylase,
elevated
activity
which
known
to
promote
pathogenesis
many
disorders,
leading
establishment
various
FTO
inhibitors.
By
combing
through
intrinsic
connections
among
four
primary
problems,
we
attribute
their
shared
pathological
cause
inflammation.
reviewing
roles
in
promoting
these
current
status
existing
inhibitors
treating
syndromes,
underpinned
paramount
potential
resolving
clinical
issues
targeting
urgent
need
establishing
novel
with
maximized
efficacy
minimized
side
effect.
Cold
atmospheric
plasma
(CAP)
fourth
state
matter
demonstrated
associated
chronic
introducing
characteristics
CAP,
proposed
it
a
possible
solution
unresolved
given
its
anti-inflammation
feature
safety.
We
also
emphasized
intensive
investigations
exploring
feasibility
using
CAP
that
might
function
FTO.
Molecular & Cellular Proteomics,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100962 - 100962
Published: April 1, 2025
The
promising
role
of
cold
atmospheric
plasma
jet
(CAPJ)
treatment
in
promoting
wound
healing
has
been
widely
documented
therapeutic
implications.
However,
the
fact
that
not
all
subjects
respond
equally
to
CAPJ
necessitates
investigation
underlying
cellular
mechanisms,
which
have
rarely
understood
so
far.
Given
is
a
complex
and
prolonged
process,
post-plasma-activated
medium
(PAM)
treated
keratinocytes
were
collected
at
two
time
points,
2
hours
(receiving)
24
(recovery),
for
(phospho)proteomic
analysis
systematically
dissect
molecular
basis
CAPJ-promoted
healing.
receiving
(phospho)proteomics
datasets,
referred
point
hours,
revealed
an
apparent
increase
phosphorylation
CK2
its-mediated
PI3K/AKT
MAPK
signaling
pathways,
accompanied
by
prompted
downstream
physiological
response
cell
migration.
Additionally,
incorporating
network
predicted
kinases
their
direct
interactors,
we
reiterated
influenced
growth
migration,
thereby
paving
way
its
subsequent
processes.
Further
determining
proteome
profiles
recovery
phase,
displayed
totally
different
view
from
had
almost
no
change.
up-regulation
ROBOs/SLITs
expression
vesicle
trafficking
fusion-related
proteins,
along
with
abundant
presence
14-3-3
family
indicated
persistent
effect
PAM
on
process
could
potentially
promote
keratinocyte-fibroblast
crosstalk
stimulate
extracellular
matrix
(ECM)
synthesis
upon
epithelialization.
Consistent
patterns,
CAPJ-treated
tissues
indeed
showed
denser
well-organized
ECM
architecture,
implying
hastened
epithelialization
during
Collectively,
delineated
CAPJ-accelerated
early
late
responses,
providing
valuable
insights
selection
development
strategies
achieve
better
outcomes.
Applied Sciences,
Journal Year:
2023,
Volume and Issue:
14(1), P. 355 - 355
Published: Dec. 30, 2023
Plasma
technology
shows
tremendous
potential
for
revolutionizing
oncology
research
and
treatment.
Reactive
oxygen
nitrogen
species
electromagnetic
emissions
generated
through
gas
plasma
jets
have
attracted
significant
attention
due
to
their
selective
cytotoxicity
towards
cancer
cells.
To
leverage
the
full
of
medicine,
researchers
explored
use
mathematical
models
various
subsets
or
approaches
within
machine
learning,
such
as
reinforcement
learning
deep
learning.
This
review
emphasizes
application
advanced
algorithms
in
adaptive
system,
paving
way
precision
dynamic
Realizing
techniques
medicine
requires
efforts,
data
sharing,
interdisciplinary
collaborations.
Unraveling
complex
mechanisms,
developing
real-time
diagnostics,
optimizing
will
be
crucial
harnessing
true
power
oncology.
The
integration
personalized
therapies,
alongside
AI
diagnostic
sensors,
presents
a
transformative
approach
treatment
with
improve
outcomes
globally.
Plasma Processes and Polymers,
Journal Year:
2024,
Volume and Issue:
21(5)
Published: Jan. 17, 2024
Abstract
In
this
work,
the
effects
of
cold
atmospheric‐pressure
plasma
(CAP)
on
glioblastoma
are
evaluated
comprehensively.
After
CAP
treatment,
U251
cell
viability,
migration,
and
invasion
functions
were
inhibited,
while
an
appropriate
dose
had
no
inhibitory
effect
human
brain
glial
line
cells.
Western
blots
indicated
that
expression
caspase‐3
was
upregulated
with
ki‐67
downregulated.
Moreover,
mitochondrial
membrane
potential
decreased,
energy
metabolisms
cells
influenced
afterward.
TUNEL
assays
comet
suggested
DNA
damage
after
treatment.
Furthermore,
as
one
responses
associated
pathways,
AKT
(AKT8
virus
oncogene
cellular
homolog)
signaling
pathway
also
in
work.
The
findings
raise
great
promise
for
clinical
applications
treatments.